1Paul D.Chan,MD,Susan M.Johnson,MD.Gynecology and Obstetrics[M].2004 Edition.Current Clinical Strategies Publishing,2004,30.
2MitchellD.Creinin,MD.Clinical management guidelines for obstetrician-gynecologists Number 26,April 2001,published by the American College of Obstetricians and Gynecologists,2001,553-556.
4Huppertz B,Peeters LL . Vascular biology in implantation and plaeentation [ J ] . Angiogenesis, 2005,8 (2) : 157-167 .
5Kingdom J,Huppertz B,Seaward G,et al . Development of the placental villous tree and its consequences for fetal growth[J]. Eur J Obstee Gynecol Reprod Biol,2000( 1 )92:35-43.
6Shore VH, Wang TH, Wang CL, et al. Vascular endothelial growth factor,Placenta growth factor and their receptors in islated human trophoblast [ J ]. Placenta, 1997,18 ( 8 ) : 657-665.
7Hyder SM, Huang JC, Nawaz Z,et al . Regulation of Vascular endothelial growth factor exprssion by estrogen and prosgestogcns[J] .Environ Health Perspect, 2000,108 (suppl 5 ) : S785-S790.
8Kusunoki T,Sugai M,Gonda H,et al.CpG inhibits IgE class switch recombination through suppression of NF kappa B activity,but not through Id2 or Bc16.Biophys Res Commun,2005,328(2):499-506.
9Karin M.NF-kappaB and cancer:mechanisms and targets.Mol Carcinog,2006,45:355-361.
10Aranha MM,Borralho PM,Ravasco P,et al.NF-kappaB and apoptosis in colorectal tumourigenesis.Eur J Clin Invest,2007,37(5):416-424.